July 23, 2024: Rise in Ozempic Lawsuits Following Study on Vision Damage Risks Ozempic lawsuits have been on the rise, especially since the publication of a previous study showing an increased risk for sudden vision damage
Research on GLP-1 Use in People With Bipolar Disorder Is Limited The original randomized, controlled trials for GLP-1s often didnt include participants with bipolar disorder, notes the nonprofit International Bipolar Foundation
In the context of AD, the focus should be on individuals at risk, such as those with MCI, subjective cognitive decline, elders with positive A or tau biomarkers, APOE -4-carriers or healthy elderly individuals with high-risk scores [105]
If you or your child must have an imaging test (like an X-ray or CT scan), make sure your doctor or dentist uses shields to protect the head, neck, and body from radiation
Koren, M
Moreover, the increasing government support, ongoing drug innovation, and expanding insurance coverage are projected to fuel the GLP-1 market growth in the region